BAD Managing People with Nodular Prurigo (Prurigo Nodularis) Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

Managing People with Nodular Prurigo (Prurigo Nodularis)

British Association of Dermatologists


Publication Date: Mar 5, 2026

Page Last Updated: May 6, 2026

Strength of Recommendation

SymbolStrengthWordingDefinition
↑↑Strong recommendation for the use of an intervention‘Offer’ (or similar, e.g. ‘use’, ‘provide’, ‘take’, ‘investigate’ etc.)Benefits of the intervention outweigh the risks; most patients would choose the intervention while only a small proportion would not; for clinicians, most of their patients would receive the intervention; for policymakers, it would be a useful performance indicator
↑Weak recommendation for the use of an intervention‘Consider’Risks and benefits of the intervention are finely balanced; most patients would choose the intervention, but many would not; clinicians would need to consider the pros and cons for the patient in the context of the evidence; for policymakers it would be a poor performance indicator where variability in practice is expected
ΘNo recommendation Insufficient evidence to support any recommendation
↓↓Strong recommendation against the use of an intervention‘Do not offer’Risks of the intervention outweigh the benefits; most patients would not choose the intervention while only a small proportion would; for clinicians, most of their patients would not receive the intervention

Document Overview

Document Title
Managing People with Nodular Prurigo (Prurigo Nodularis)
Authoring Society

British Association of Dermatologists

Document Publication Date
Mar 5, 2026
Page Last Reviewed/Updated
May 6, 2026
Document Type
Guideline
Country of Publication
United Kingdom
Full Text Freely Available
Yes
Full Text Guideline
academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljag070/8506828
Source Citation
Millington, George W M et al. “British Association of Dermatologists living guideline for managing people with nodular prurigo (prurigo nodularis) 2025.” The British journal of dermatology, ljag070. 5 Mar. 2026, doi:10.1093/bjd/ljag070

Document Scope, Criteria, and Use Cases

Document Objectives
The overall objective of the current iteration of this living guideline is to provide up-to3 date, evidence-based recommendations for the management of nodular prurigo (NP; prurigo nodularis) in adults (≥18 years of age), children (0-12 years of age) and young people (13-17 years of age). The document aims to:
  • offer an appraisal of all relevant literature up to 25 April 2025, focusing on any key 7 developments
  • address important, practical clinical questions relating to the primary guideline objective
  • provide guideline recommendations and if appropriate research recommendations
Scope
Assessment and Screening, Management, Treatment
Diseases/Conditions (MeSH)

D011536 - Prurigo

Keywords
Prurigo, prurigo nodularis
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older Adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant, Psychologist
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.